SGO2 and central nervous system cancer: Then, the Gene Expression Omnibus (GEO) dataset profiles, The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), RT-PCR, and Western blotting analysis suggested that SGO2 might be a new prognostic biomarker for human gliomas.